1, 3, 4-oxadiazole compound containing morpholine group as well as preparation method and application thereof

A technology of oxadiazoles and compounds, applied in the field of medicinal chemistry, can solve the problems of high phytotoxicity of rice leaves

Pending Publication Date: 2021-11-12
GUIZHOU UNIV
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In our previous work, we developed and evaluated the antibacterial function of a series of pyridinium tailor-

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 1, 3, 4-oxadiazole compound containing morpholine group as well as preparation method and application thereof
  • 1, 3, 4-oxadiazole compound containing morpholine group as well as preparation method and application thereof
  • 1, 3, 4-oxadiazole compound containing morpholine group as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: Preparation of intermediate 2-((8-bromooctyl)thiol)-5-phenyl-1,3,4-oxadiazole

[0048] 5-phenyl-1,3,4-oxadiazole-2-thiol (1mmol), K 2 CO 3 (1.3mmol) and 8mL DMF were added into a 25mL round bottom flask, then 1,8-dibromooctane (1.3mmol) was added and stirred at room temperature for 2 hours to end the reaction. Precipitation, column chromatography (eluent petroleum ether [ethyl acetate = 10 [1, V / V]) to obtain the intermediate. At the same time, for intermediates with other chain lengths, except that 1,8-dibromooctane was replaced with different chain lengths, the experimental steps and feeding ratio of other intermediates were consistent with those in Example 1.

Embodiment 2

[0049] Example 2: 4-methyl-4-(8-((5-phenyl-2-1,3,4-oxadiazolyl)thiol)octyl)morpholin-4-ium bromide

[0050] 2-((8-Bromooctyl)thiol)-5-phenyl-1,3,4-oxadiazole (0.4 mmol) and 4-methylmorpholine (4.55 mmol) were dissolved in 4 mL of CH 3 CN and put it into a 15mL reaction flask, and reflux at 85°C for 8h. TLC followed the completion of the reaction. Water (3 x 20 mL) and ethyl acetate (50 mL) were added for extraction. The organic phase was anhydrous Na 2 SO 4 Dry, filter with suction, and concentrate under reduced pressure. The crude residue was further purified by silica gel column chromatography using CH 2 Cl 2 and CH 3 OH (20:1, v / V) was used as the eluent to obtain a light yellow solid with a yield of 63.2%. The rest of the experimental steps and feeding ratios were consistent with those in Example 2.

[0051] The remaining 1,3,4-oxadiazole compounds containing morpholine groups were synthesized according to the steps of Examples 1 and 2 using corresponding raw mater...

Embodiment 3

[0076] Based on compound 12 showing the best activity against rice bacterial blight (EC 50 1.40 μg / mL), the in vivo pot experiment of compound 12 on rice bacterial blight was carried out. The specific experimental steps are as follows:

[0077] Protective activity: Compound 12 and the control drug chlorfenadin (20% content preparation) were formulated into a 200 μg / mL drug-containing solution with less than 1% Tween20 solution, and two more compound 12 solutions with a concentration of 200 μg / mL were prepared; Spray the prepared medicinal solution on the surface of rice leaves that have been grown for 8 weeks until there are drops; 595 = 0.6-0.8 The scissors of rice bacterial blight bacteria in the range of 0.8 cut off the tip of the leaf, and soak the wound in the bacterial solution for about 10 seconds. The equal amount of DMSO and the bacterial leaf without adding the drug are set as a control. Each treatment has three After 14 days, check the disease situation, record th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to 1, 3, 4-oxadiazole compounds containing a morpholine group as well as a preparation method and application thereof. The compound has a structure as shown in a general formula (I) which is described in the specification. On the basis of a derivative containing a 1, 3, 4-oxadiazole group, a morpholine group capable of improving the biological activity of a target compound is introduced into the system. The compound has a good inhibition effect on pathogenic fungi and bacteria, such as Xanthomonas oryzae pv. Oryzae, Xanthomonas axonopodis pv. citri, fusarium oxysporum, and blueberry root rot.

Description

technical field [0001] The application relates to the technical field of medicinal chemistry, in particular to a 1,3,4-oxadiazole compound containing a morpholine group and its preparation method and application. Background technique [0002] Plant pathogens are a group of invasive microorganisms that are widely distributed around the world. They can invade various plants to compete for nutrients and reproduce themselves, and cause serious diseases of important crops, seriously threatening the quality and yield of agricultural products. For example, Gibberella saubinetii is a filamentous ascomycete, which is caused by a variety of Fusarium infection and occurs on wheat. The pathogen can cause wheat seedling rot, stalk rot, stem rot and ear rot, and it brings at least 10-20% yield reduction to wheat-growing countries every year. In addition, rice bacterial blight (Xanthomonasoryza epv. Oryzae) is a rod-shaped Gram-negative bacterium that can cause the leaves of rice to withe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D271/113A01N43/824A01P1/00A01P3/00
CPCC07D271/113A01N43/82
Inventor 杨松庹鑫鑫张业东王培义吉庆田刘青青
Owner GUIZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products